• #1184408
  • Glaxo Specialty #49702024015

CABENUVA Cabotegravir / Rilpivirine 600 mg - 900 mg Injection Single Dose Vial Kit

CABENUVA KIT, SDV 600MG/900MG

Features
  • CABENUVA is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine
  • Requires Refrigeration
  • Intramuscular (IM) gluteal
  • More …
Strength
400 mg - 600 mg 600 mg - 900 mg
  Log In to Order
or

Product Specifications


McKesson #1184408
Manufacturer #49702024015
BrandCABENUVA
ManufacturerGlaxo Specialty
Country of OriginUnknown
ApplicationAntiretroviral
Container TypeSingle Dose Vial Kit
Dosage FormInjection
Generic Drug NameCabotegravir / Rilpivirine
NDC Number49702-0240-15
Product DatingMcKesson Acceptable Dating: we will ship >= 90 days
Storage RequirementsRequires Refrigeration
Strength600 mg - 900 mg
TypeIntramuscular
UNSPSC Code51343800
Features
  • CABENUVA is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine
  • Requires Refrigeration
  • Intramuscular (IM) gluteal

Professionals Also Viewed